Back to results
US 2004/0071718 A1Published application
Local nasal immunotherapy for allergen-induced airway inflammation
OwnerJaw-Ji Tsaiinventor
Life of this patent
Estimating the term…
Abstract
Methods and pharmaceutical compositions for treating allergen-induced airway inflammation. The method includes administering a therapeutically effective amount of a pharmaceutical composition comprising a Dermatophoides pteronyssinus group 2 (Dp2) epitope peptide and a pharmaceutically acceptable carrier to an individual having allergen-induced airway inflammation, in a manner consistent with local nasal immunotherapy.
Claims20
A method for treating allergen-induced airway inflammation, comprising the steps of:
- administering a therapeutically effective amount of a pharmaceutical composition comprising a Dermatophoides pteronyssinus group 2 (Dp2) epitope peptide and a pharmaceutically acceptable carrier to an individual having allergen-induced airway inflammation in a manner consistent with local nasal immunotherapy.
A pharmaceutical composition for treating allergen-induced airway inflamation in an individual, comprising:
- a Dermatophoided pyeronssinus group 2 )Dp2) epitope peptide;
- and
- a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.